| AbbVie AG - Alphagan, Augentropfen |
| 54605 | | 01 | | Alphagan | | Augentropfen | | S01EA05 | | Brimonidine | | 10.12.1998 | | |
|
| Composition |
| brimonidini tartras 2 mg corresp. brimonidinum 1.3 mg, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, poly(alcohol vinylicus), benzalkonii chloridum 50 µg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Eye drops | | | | | | | | Active Agent | Dose |
|---|
| Brimonidine Tartrate | 2 mg/ml correspond Brimonidine 1.3 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Brimonidine Tartrate | 2 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Aqua Purificata | | | Benzalkonium Chloride | 50 µg/ml | | Sodium Chloride | | | Natrii Citras Dihydricus | | | Poly(Alcohol Vinylicus) | |
| |
|
|
